Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathalie Labarriere

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Plos One|October 3, 2013
The melanoma antigens MELOE-1 and MELOE-2 are translated from a bona fide polycistronic mRNA containing functional IRES sequencesDelphine Carbonnelle, Virginie Vignard, Delphine Sehedic, et al.
Frontiers in Immunology|September 15, 2018
TCR Analyses of Two Vast and Shared Melanoma Antigen-Specific T Cell Repertoires: Common and Specific FeaturesSylvain Simon, Zhong Wu, J Cruard, et al.
Cancer Research|December 8, 2017
Emergence of High-Avidity Melan-A-Specific Clonotypes as a Reflection of Anti-PD-1 Clinical EfficacySylvain Simon, Virginie Vignard, Emilie Varey, et al.
Cellular Immunology|September 2, 2019
Viral and tumor antigen-specific CD8 T-cell responses in Merkel cell carcinomaMahtab Samimi, Houssem Benlalam, Pascal Aumond, et al.
Oncoimmunology|July 10, 2024
Differential impact of genetic deletion of TIGIT or PD-1 on melanoma-specific T-lymphocytesGwenann Cadiou, Tiffany Beauvais, Lucine Marotte, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2005
Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cellsVirginie Vignard, Brigitte Lemercier, Annick Lim, et al.
Journal for Immunotherapy of Cancer|February 1, 2020
Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytesLucine Marotte, Sylvain Simon, Virginie Vignard, et al.
Journal for Immunotherapy of Cancer|November 14, 2020
PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapySylvain Simon, Valentin Voillet, Virginie Vignard, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Plos One|October 3, 2013
The melanoma antigens MELOE-1 and MELOE-2 are translated from a bona fide polycistronic mRNA containing functional IRES sequencesDelphine Carbonnelle, Virginie Vignard, Delphine Sehedic, et al.
Frontiers in Immunology|September 15, 2018
TCR Analyses of Two Vast and Shared Melanoma Antigen-Specific T Cell Repertoires: Common and Specific FeaturesSylvain Simon, Zhong Wu, J Cruard, et al.
Cancer Research|December 8, 2017
Emergence of High-Avidity Melan-A-Specific Clonotypes as a Reflection of Anti-PD-1 Clinical EfficacySylvain Simon, Virginie Vignard, Emilie Varey, et al.
Cellular Immunology|September 2, 2019
Viral and tumor antigen-specific CD8 T-cell responses in Merkel cell carcinomaMahtab Samimi, Houssem Benlalam, Pascal Aumond, et al.
Oncoimmunology|July 10, 2024
Differential impact of genetic deletion of TIGIT or PD-1 on melanoma-specific T-lymphocytesGwenann Cadiou, Tiffany Beauvais, Lucine Marotte, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2005
Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cellsVirginie Vignard, Brigitte Lemercier, Annick Lim, et al.
Journal for Immunotherapy of Cancer|February 1, 2020
Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytesLucine Marotte, Sylvain Simon, Virginie Vignard, et al.
Journal for Immunotherapy of Cancer|November 14, 2020
PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapySylvain Simon, Valentin Voillet, Virginie Vignard, et al.
Pageof 2